ANDE
The Andersons, Inc.
ANDE's fundamentals are mixed, but it looks cheap: trading at 9.2x earnings, below its usual 15x. Analysts expect strong earnings growth, though they disagree widely on how much.
ANDE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Stable |
ANDE's profitability is currently healthy, and its revenue and balance sheet are stable, but its cash flow is under pressure.
ANDE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.7x | $54.87 | — |
| Current | 9.2x | $54.87 | — |
| Cheap | 11x | $68.18 | +24% |
| Fair | 15x | $87.42 | +59% |
| Expensive | 24x | $144 | +163% |
Historical ranges are pointers, not guarantees.
ANDE's PE is in its cheap range at 9.2x. If earnings grow as analysts expect, today's price would be 8.7x next year's earnings.
ANDE Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect ANDE's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ANDE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.34 | +6.7% |
| Q3 2026 | $5.94 | +178% |
| Q2 2026 | $5.17 | +120% |
| Q1 2026 | $3.75 | +18% |
| Q4 2025 | $2.79 | -16% |
| Q3 2025 | $2.14 | -39% |
| Q2 2025 | $2.35 | -21% |
| Q1 2025 | $3.17 | -10% |
| Q4 2024 | $3.32 | +13% |
ANDE earned $5.94 per share over the past year, up 178% from the year before.
ANDE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8B | +5.8% |
| Q2 2026 | $3.1B | -1.2% |
| Q1 2026 | $2.6B | -1.2% |
| Q4 2025 | $2.5B | -19% |
| Q3 2025 | $2.7B | +2.2% |
| Q2 2025 | $3.1B | +12% |
| Q1 2025 | $2.7B | -2.2% |
| Q4 2024 | $3.1B | -2.8% |
ANDE's revenue is recovering but still below its 2022 peak: $2.8B last quarter, up 5.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.8% | +0.8 points |
| Q2 2026 | 2.2% | +1.4 points |
| Q1 2026 | 1.3% | +1.2 points |
| Q4 2025 | 3.5% | +1.3 points |
| Q3 2025 | 1% | -1.4 points |
| Q2 2025 | 0.8% | -1.3 points |
| Q1 2025 | 0.1% | -0.4 points |
| Q4 2024 | 2.1% | -0.7 points |
ANDE's operating margin was 1.8% last quarter, up 0.8 points from the same quarter a year ago.
ANDE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$183.8M | -210% |
| Q2 2026 | $412.4M | +65% |
| Q1 2026 | -$445.4M | -$48.8M |
| Q4 2025 | -$77.1M | -136% |
| Q3 2025 | $167M | +$207M |
| Q2 2025 | $250.5M | -9.2% |
| Q1 2025 | -$396.6M | -$130.2M |
| Q4 2024 | $212.9M | +1.9% |
ANDE's free cash flow was −$294M over the past year, against $234M the year before.
ANDE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -63K shares |
| 1 year | +0.1% | +25K shares |
| 3 years | -0.2% | -61K shares |
| 5 years | +1.7% | +575K shares |
| Available history | +3.4% | +1.1M shares |
ANDE has 34M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $14.5M |
| Q4 2025 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $76,000 |
| Q1 2023 | $1.7M |
| Q4 2022 | $6M |
ANDE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.7x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 4.1x | High |
| Q4 2025 | 1.9x | Healthy |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 0.3x | Very low |
ANDE's net debt is about 2.7 years of its operating earnings (EBITDA), about the same as a year ago.
ANDE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.3 | Neutral |
| Stochastic | 9.2 | Oversold |
ANDE's weekly RSI is 34 (neutral) and its Stochastic is 9 (oversold).
ANDE PE vs Consumer Defensive Sector
| Metric | ANDE | Sector median | Relative |
|---|---|---|---|
| PE | 9.2x | 19x | 53% below |
| PE % | 7 | 18 | 11 pts below |
ANDE is trading at 9.2x earnings, a 53% discount to the Consumer Defensive sector's median of 19x.
ANDE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.8 | 13% below |
| 20 week MA | $67.1 | 18% below |
| 50 week MA | $66.6 | 18% below |
| 100 week MA | $53.6 | 2.4% above |
| 200 week MA | $51.3 | 7.1% above |
ANDE has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 7.1% above its 200-week average.
ANDE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.7 | $23.8 | -3.8% |
| 2021 | $23.8 | $38.1 | +60% |
| 2022 | $38.1 | $36.0 | -5.5% |
| 2023 | $36.0 | $57.5 | +60% |
| 2024 | $57.5 | $40.1 | -30% |
| 2025 | $40.1 | $53.3 | +33% |
| 2026 YTD | $53.3 | $54.9 | +2.9% |
ANDE has finished lower in three of the last six years. It's up 2.9% so far in 2026.